For the last few years Valeant Pharmaceuticals has been buying big medical brands like Bausch & Lomb. Forbes looks at whether the latest decision to team up with hedge fund manager William Ackman in a bid to acquire Botox-maker Allergan could work. Also, Ackman tells CNBC that he did not front-run Allergan stock.